Long answer question ( 15 marks ) 1. Describe the denovo - synthesis of purine nucleotides. 2. Explain the metabolic pathway for tge biosynthesis of pyrimidine nucleotides 3. Explain the detail the semi- conservation replication of double standard DNA molecules. Add a note on its repair mechanism. 4. Explain in detail about biosynthesis of proteins? 5. Define mutation ? Explain various types of mutation. Short answer ( 5 marks ) 1. Describe the different DNA repair mechanism? 2. Define genetic code and describe its characterstic feature? 3. What is leading and lagging strands of DNA . 4. Explain the nucleotides? Givr the name of 4 nucleotides. 5. What is onion peel model of DNA replication . Briefly explain. 6. What are okazaki fragments? What is gout? high yield marks and for university level checker give extra marks impressive format in easy language try to have same basic concepts and simple words through which examiner can easily understand what's written including flowcharts , diagrams in understanable language

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have all the core content needed. Let me compose the complete, comprehensive exam answer set.

📚 BIOCHEMISTRY EXAM ANSWERS — UNIVERSITY LEVEL

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

📝 LONG ANSWER QUESTIONS (15 Marks Each)

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

LONG ANSWER 1 — De Novo Synthesis of Purine Nucleotides

Introduction

Purine nucleotides (AMP and GMP) are essential for DNA, RNA, coenzymes (NAD⁺, FAD, CoA), energy carriers (ATP), and second messengers (cAMP). The body can synthesize purines from scratch — this is called de novo synthesis (meaning "from the beginning"). The process mainly occurs in the liver and involves building the purine ring step by step on a pre-formed ribose sugar scaffold.

Precursors of the Purine Ring

The atoms of the purine ring come from several sources:

┌────────────────────────────────────────────────────┐
│           PURINE RING ATOM SOURCES                 │
│                                                    │
│  N1  ← Aspartate                                   │
│  C2  ← N10-formyl THF (folate)                     │
│  N3  ← Glutamine (amide nitrogen)                  │
│  C4  ← Glycine                                     │
│  C5  ← Glycine                                     │
│  N7  ← Glycine                                     │
│  C6  ← CO₂                                         │
│  N9  ← Glutamine (amide nitrogen)                  │
│  C8  ← N10-formyl THF (folate)                     │
└────────────────────────────────────────────────────┘

Key memory trick: "G-Gal C Foolish" → Glycine, Glutamine, Aspartate, CO₂, Folate (THF)

Step-by-Step Pathway (Flowchart)

GLUCOSE 6-PHOSPHATE
        ↓ (Pentose Phosphate Pathway)
RIBOSE 5-PHOSPHATE
        ↓ + ATP  [PRPP Synthetase]
5-PHOSPHORIBOSYL-1-PYROPHOSPHATE (PRPP)  ← KEY STARTING POINT
        ↓ + Glutamine  [GPAT enzyme — COMMITTED STEP ⭐]
5-PHOSPHORIBOSYLAMINE (PRA)
        ↓ + Glycine, ATP
GLYCINAMIDE RIBONUCLEOTIDE (GAR)
        ↓ + N10-formyl THF
FORMYLGLYCINAMIDE RIBONUCLEOTIDE (FGAR)
        ↓ + Glutamine, ATP
FORMYLGLYCINAMIDINE RIBONUCLEOTIDE (FGAM)
        ↓ + CO₂, ATP
5-AMINOIMIDAZOLE RIBONUCLEOTIDE (AIR)
        ↓ + CO₂
CAIR (Carboxyaminoimidazole ribonucleotide)
        ↓ + Aspartate, ATP
SAICAR
        ↓ (Fumarate released)
AICAR
        ↓ + N10-formyl THF
FAICAR
        ↓ (Ring closure, H₂O released)
INOSINE MONOPHOSPHATE (IMP)  ← FIRST COMPLETE PURINE
        ↙                  ↘
    + Aspartate           + Glutamine + XMP
        ↓                        ↓
     AMP (Adenylate)         GMP (Guanylate)
        ↓                        ↓
     ADP → ATP              GDP → GTP

Key Enzymes & Regulation

Step	Enzyme	Significance
PRPP synthesis	PRPP Synthetase	Activated by Pi; inhibited by AMP, GMP, IMP
PRA synthesis	GPAT (Glutamine:PRPP amidotransferase)	Committed step; inhibited by AMP & GMP
IMP → AMP	Adenylosuccinate synthetase + lyase	Requires GTP
IMP → GMP	IMP dehydrogenase + GMP synthetase	Requires ATP

Cross-regulation: AMP synthesis needs GTP, and GMP synthesis needs ATP — this ensures balanced production of both purines.

        AMP ──┐         GMP ──┐
              │               │
        inhibits           inhibits
              ↓               ↓
        IMP → AMP      IMP → GMP
        (uses GTP)     (uses ATP)

Salvage Pathway (Brief Note)

Instead of making purines from scratch, cells can recycle free bases from cell turnover:

Hypoxanthine + PRPP → IMP (by HGPRT enzyme)
Adenine + PRPP → AMP (by APRT enzyme)

Lesch-Nyhan Syndrome = HGPRT deficiency → Excess uric acid, gout, self-mutilation.

Clinical Relevance

Drug	Target	Use
Methotrexate, 5-FU	Inhibit folate metabolism (blocks formyl-THF steps)	Cancer
6-Mercaptopurine	Inhibits GPAT (committed step)	Leukemia
Allopurinol	Inhibits xanthine oxidase	Gout

Source: Lippincott's Biochemistry, 8th ed., Chapter 22

LONG ANSWER 2 — Biosynthesis of Pyrimidine Nucleotides

Introduction

Unlike purines (built on ribose), the pyrimidine ring is built first and then attached to ribose 5-phosphate. Pyrimidines include cytosine (C), thymine (T), and uracil (U). Synthesis occurs in the cytoplasm. The liver is the major site, but all cells can do it.

Precursors

┌──────────────────────────────────────────┐
│     PYRIMIDINE RING ATOM SOURCES         │
│                                          │
│   N1     ←  Aspartate                    │
│   C2     ←  CO₂ (from carbamoyl PO₄)    │
│   N3     ←  Glutamine                    │
│   C4, C5, C6 ←  Aspartate               │
└──────────────────────────────────────────┘

Simple rule: Aspartate + CO₂ + Glutamine build the pyrimidine ring.

De Novo Pathway — Flowchart

GLUTAMINE + CO₂ + 2ATP
        ↓  [Carbamoyl Phosphate Synthetase II — CPS II]
        ↓  (in CYTOPLASM — different from CPS I in urea cycle)
CARBAMOYL PHOSPHATE
        ↓ + Aspartate  [Aspartate Transcarbamoylase — ATCase ⭐ REGULATED STEP]
N-CARBAMOYL ASPARTATE
        ↓  [Dihydroorotase] (ring closure)
DIHYDROOROTATE
        ↓  [Dihydroorotate dehydrogenase — on inner mitochondrial membrane]
OROTATE (first pyrimidine)
        ↓ + PRPP  [Orotate phosphoribosyltransferase]
OROTIDINE 5'-MONOPHOSPHATE (OMP)
        ↓  [OMP decarboxylase] — fastest known enzyme!
URIDINE MONOPHOSPHATE (UMP)
        ↓↓ (2 kinase steps)
UTP
 ├──────────────────────────────────────────────┐
 ↓ + Glutamine [CTP Synthetase]                 ↓
CTP                                        dUMP + N5,N10-methylene THF
                                                ↓ [Thymidylate Synthase]
                                               dTMP → dTTP  (DNA only)

Regulation Summary

Enzyme	Regulated by
CPS II	Inhibited by UMP; activated by PRPP & ATP
ATCase	Inhibited by CTP (end-product); activated by ATP
OMP decarboxylase	Inhibited by UMP and CMP

Key Points

CAD Protein (in mammals) = trifunctional enzyme combining CPS II + ATCase + Dihydroorotase = first 3 steps in one protein
UMP is the precursor to all other pyrimidines
Thymidylate synthase converts dUMP → dTMP using N5,N10-methylene THF → this step is targeted by 5-fluorouracil (5-FU) in cancer therapy
Dihydroorotate dehydrogenase is the only mitochondrial step; inhibited by leflunomide (used in rheumatoid arthritis)

Pyrimidine vs Purine Synthesis — Quick Comparison

┌──────────────────┬────────────────────────────┬──────────────────────────────┐
│ Feature          │ Purine                     │ Pyrimidine                   │
├──────────────────┼────────────────────────────┼──────────────────────────────┤
│ Ring built       │ On ribose (step-by-step)   │ Before attachment to ribose  │
│ First product    │ IMP                        │ UMP                          │
│ Precursors       │ Gln, Gly, Asp, CO₂, THF   │ Gln, Asp, CO₂                │
│ Committed step   │ PRA formation (GPAT)       │ Carbamoyl-Asp (ATCase)       │
│ Shared step      │ PRPP needed                │ PRPP needed                  │
└──────────────────┴────────────────────────────┴──────────────────────────────┘

Source: Lippincott's Biochemistry, 8th ed., Chapter 22

LONG ANSWER 3 — Semiconservative Replication of Double-Stranded DNA + Repair Mechanisms

Introduction

DNA replication is the process by which a cell duplicates its DNA before cell division, ensuring that each daughter cell receives an exact copy of the genome. In 1958, Meselson and Stahl proved that DNA replication is semiconservative using ¹⁵N labeling experiments.

Semiconservative Replication — Concept

PARENT DNA:
    5'——————————————————3'   (Old strand)
    3'——————————————————5'   (Old strand)

After ONE replication cycle:
┌──────────────────────┐    ┌──────────────────────┐
│ Daughter Molecule 1  │    │ Daughter Molecule 2  │
│  OLD strand (3'→5')  │    │  OLD strand (5'→3')  │
│  NEW strand (5'→3')  │    │  NEW strand (3'→5')  │
└──────────────────────┘    └──────────────────────┘
Each new DNA has ONE old strand + ONE new strand

"Semi" = half conserved; each daughter keeps one parental strand

Meselson-Stahl Experiment

E. coli grown in ¹⁵N (heavy) medium → All DNA is heavy (¹⁵N/¹⁵N)
                ↓ Transfer to ¹⁴N (light) medium
After 1st generation → All DNA is HYBRID (¹⁵N/¹⁴N) — 1 band at intermediate density
After 2nd generation → HYBRID (¹⁵N/¹⁴N) + LIGHT (¹⁴N/¹⁴N) — 2 bands
→ PROVES SEMICONSERVATIVE replication ✓

Steps in DNA Replication

Step 1 — Initiation

Starts at Origin of Replication (ori); AT-rich sequences melt easily
DnaA protein (prokaryotes) or ORC complex (eukaryotes) recognizes ori
Helicase (DnaB) unwinds the double helix → creates Replication Fork
Two forks form, moving in opposite directions (bidirectional replication)
SSBPs (Single-Strand Binding Proteins) stabilize the unwound strands
Topoisomerase I & II relieve the torsional tension (supercoiling) ahead of the fork

         Origin (ori)
            ↓
    ←───────●───────→
   Fork 1              Fork 2
 (moves left)        (moves right)

Step 2 — Primer Synthesis

DNA polymerase cannot start a new chain; it can only extend
Primase (an RNA polymerase) synthesizes a short RNA primer (~10 nucleotides) at the origin
The primer gives a free 3'-OH group for DNA pol to start adding nucleotides

Step 3 — Elongation

         5' ←─────────────────────── 3'   (Template)
              ← ← ← Leading strand (continuous, 5'→3')

         3' ──────────────────────→  5'   (Template)
               Okazaki Fragment 1
               [←──────]  RNA primer
               Okazaki Fragment 2
               [←──────]  RNA primer
               (Lagging strand — discontinuous synthesis)

Strand	Synthesis	Direction
Leading strand	Continuous	5' → 3' toward fork
Lagging strand	Discontinuous (Okazaki fragments)	5' → 3' away from fork

DNA Pol III (prokaryotes) or Pol δ/ε (eukaryotes) does the main synthesis
Uses dNTPs (dATP, dGTP, dCTP, dTTP) as substrates
PPi released → hydrolyzed to 2Pi → drives reaction forward

Step 4 — Primer Removal & Gap Filling

DNA Pol I (prokaryotes) removes RNA primers and fills gaps using its 5'→3' exonuclease + polymerase activities
In eukaryotes: RNase H + FEN1 remove primers

Step 5 — Ligation

DNA Ligase seals the nicks between adjacent Okazaki fragments using NAD⁺ (prokaryotes) or ATP (eukaryotes) as energy
Final result: two complete daughter DNA molecules

DNA Replication Enzymes Summary

┌──────────────────────┬────────────────────────────────────────────────┐
│ Enzyme               │ Function                                       │
├──────────────────────┼────────────────────────────────────────────────┤
│ DnaA / ORC           │ Recognizes origin of replication               │
│ Helicase (DnaB)      │ Unwinds double helix (uses ATP)                │
│ Topoisomerase I/II   │ Relieves supercoiling ahead of fork            │
│ SSBP                 │ Stabilizes single-stranded template            │
│ Primase              │ Synthesizes RNA primer                         │
│ DNA Pol III          │ Main synthesis enzyme (prokaryotes)            │
│ DNA Pol I            │ Removes primers, fills gaps                    │
│ DNA Ligase           │ Seals nicks, joins Okazaki fragments           │
│ β-clamp (Sliding clamp)│ Keeps Pol III attached to template          │
└──────────────────────┴────────────────────────────────────────────────┘

Note on DNA Repair Mechanisms

Errors or damage to DNA (from replication mistakes, UV light, radiation, chemicals) can be fatal to cells. Several repair systems exist:

1. Proofreading (3'→5' Exonuclease Activity)

Built into DNA Pol III (prokaryotes) and Pol δ (eukaryotes)
After adding each nucleotide, the enzyme checks for mismatch
If wrong → removes the nucleotide and inserts the correct one
Reduces error rate from 10⁻⁵ to 10⁻⁷

2. Mismatch Repair (MMR)

Corrects mismatched bases AFTER replication (escaped proofreading)
MutS recognizes the mismatch; MutL + MutH excise the wrong segment; Pol III + Ligase fill and seal
In humans: hMLH1, hMSH2 etc. → mutations cause Lynch syndrome (hereditary colorectal cancer)

3. Base Excision Repair (BER)

Fixes small, non-bulky base lesions (e.g., deaminated cytosine → uracil)
DNA glycosylase removes damaged base → creates AP site (abasic)
AP endonuclease cuts the backbone → Pol β fills gap → Ligase seals

4. Nucleotide Excision Repair (NER)

Fixes bulky DNA lesions (e.g., thymine dimers from UV light)
Excinuclease cuts 5-8 nucleotides on each side → removes ~12-24 nt oligomer
Pol I/Pol δ fills the gap; Ligase seals
Defect → Xeroderma Pigmentosum (XP) — extreme UV sensitivity, skin cancers

5. Photoreactivation (Light Repair)

Specific for UV-induced thymine dimers
Photolyase enzyme uses visible light energy to break the thymine dimer directly
Not present in placental mammals

6. Double-Strand Break Repair

Homologous Recombination (HR): Uses sister chromatid as template; accurate; active in S/G2 phase
Non-Homologous End Joining (NHEJ): Directly ligates broken ends; error-prone; active in G1 phase
BRCA1/BRCA2 mutations → defective HR → breast/ovarian cancer

DNA Repair — Summary Table

┌──────────────────────┬────────────────────┬──────────────────────────────────┐
│ Repair Type          │ Lesion Fixed        │ Key Enzyme                       │
├──────────────────────┼────────────────────┼──────────────────────────────────┤
│ Proofreading         │ Replication errors │ DNA Pol III (3'→5' exonuclease)  │
│ Mismatch Repair      │ Mismatched bases   │ MutS, MutL, MutH                 │
│ Base Excision Repair │ Deamination/oxidation│ DNA glycosylase, AP endonuclease│
│ Nucleotide Exc. Rep  │ Thymine dimers     │ Excinuclease complex             │
│ Photoreactivation    │ Thymine dimers     │ Photolyase                       │
│ NHEJ / HR            │ dsDNA breaks       │ Ku70/80, BRCA1/2                 │
└──────────────────────┴────────────────────┴──────────────────────────────────┘

Source: Lippincott's Biochemistry, 8th ed., Chapters 30–31

LONG ANSWER 4 — Biosynthesis of Proteins (Translation)

Introduction

Protein biosynthesis, or translation, is the process of converting the genetic information stored in mRNA into a sequence of amino acids (a polypeptide). It occurs in the cytoplasm on ribosomes and follows the rules of the genetic code.

Overview Flowchart

DNA  ──[Transcription]──→  mRNA  ──[Translation]──→  Protein
(Nucleus)                 (mRNA exported)            (Ribosome)

Components Required

┌──────────────────────────────────────────────┐
│         COMPONENTS FOR TRANSLATION           │
│                                              │
│  1. mRNA (contains codons to be read)        │
│  2. Ribosomes (rRNA + proteins)              │
│     - Prokaryote: 70S (50S + 30S)            │
│     - Eukaryote:  80S (60S + 40S)            │
│  3. tRNA (anticodon + amino acid)            │
│  4. Aminoacyl-tRNA synthetases               │
│  5. Initiation, Elongation, Release factors  │
│  6. ATP, GTP (energy)                        │
│  7. Mg²⁺, K⁺ ions                            │
└──────────────────────────────────────────────┘

Step 1 — Aminoacyl-tRNA Formation (Charging of tRNA)

Before translation, each amino acid must be attached to its tRNA. This requires 2 ATP equivalents:

Amino Acid + ATP  →  Aminoacyl-AMP + PPi
Aminoacyl-AMP + tRNA  →  Aminoacyl-tRNA + AMP

[Enzyme: Aminoacyl-tRNA Synthetase — specific for each amino acid]

This is called the "2nd genetic code" — it ensures correct amino acid is on the right tRNA.

Step 2 — Initiation

In Prokaryotes (e.g., E. coli):

mRNA ─ 5'─ Shine-Dalgarno sequence ──AUG─ (Start codon)─ 3'
                                     ↓
                          Methionine (fMet) — formylmethionine
                                     ↓
30S ribosome + mRNA + fMet-tRNAf  → 30S Initiation Complex
      + 50S ribosome → 70S Initiation Complex  [needs IF1, IF2 (GTP), IF3]

In Eukaryotes:

40S small subunit binds m7G cap of mRNA (cap-dependent) with eIF4E
Scans 5'→3' for AUG start codon (Kozak sequence)
Initiator amino acid is methionine (Met) (not formylated)
60S joins → 80S ribosome (requires eIF2, eIF3, eIF4, GTP)

Step 3 — Elongation

The ribosome has 3 sites for tRNA:

     ┌─────┬─────┬─────┐
     │  E  │  P  │  A  │
     │(Exit)│(Pep)│(Ami)│
     └─────┴─────┴─────┘
       ↑        ↑      ↑
  Used tRNA   Growing  New incoming
  leaves      peptide  aminoacyl-tRNA
              chain

Elongation Cycle (repeat for each amino acid):

1. DECODING/CODON RECOGNITION:
   Aminoacyl-tRNA enters A-site (helped by EF-Tu·GTP in prokaryotes)
   Anticodon pairs with mRNA codon
   GTP hydrolysis → EF-Tu·GDP released

2. PEPTIDE BOND FORMATION (Transpeptidation):
   Peptidyl transferase (23S rRNA in prokaryotes) catalyzes:
   Peptide from P-site tRNA attacks amino acid in A-site
   [This is RIBOZYME activity — rRNA acts as enzyme]
   Peptide chain transfers to A-site tRNA

3. TRANSLOCATION:
   Ribosome moves 3 nucleotides (1 codon) in 5'→3' direction
   EF-G·GTP (prokaryotes) / EF2·GTP (eukaryotes) required
   A-site tRNA (now holding peptide) → moves to P-site
   P-site tRNA (empty) → moves to E-site → exits
   New A-site is empty and ready for next aminoacyl-tRNA

Step 4 — Termination

Stop codons (UAA, UAG, UGA) — no tRNA recognizes these
Release factors (RF) bind instead:
- Prokaryotes: RF1 (recognizes UAA, UAG), RF2 (UAA, UGA), RF3 (GTP)
- Eukaryotes: eRF1 (all 3 stop codons), eRF3 (GTP)
Peptidyl transferase hydrolyzes peptide from P-site tRNA
Polypeptide is released
Ribosome dissociates into subunits

     STOP CODON (UAA/UAG/UGA)
            ↓
       RF binds A-site
            ↓
    Peptide released from P-site tRNA
            ↓
   70S/80S ribosome dissociates

Post-Translational Modifications

After the peptide chain is released, it may undergo:

Folding (chaperone proteins help, e.g., Hsp70)
Cleavage of signal peptide
Glycosylation (addition of sugars)
Phosphorylation, acetylation, methylation
Disulfide bond formation (in ER)

Energy Cost of Translation

Step	Energy Used
Aminoacyl-tRNA formation	2 ATP (per amino acid)
EF-Tu binding	1 GTP
Translocation	1 GTP
Total per peptide bond	~4 high-energy bonds

Polysome (Polyribosome)

Multiple ribosomes can translate the same mRNA simultaneously → polysome (polyribosome). This increases protein production efficiency.

5'─────────────────────────────3'  mRNA
    Rib1    Rib2    Rib3    Rib4
    [|||]   [|||]   [|||]   [|||]
    short   ↑       ↑       growing
    peptide  peptides        long peptide

Source: Lippincott's Biochemistry, 8th ed.; Harper's Biochemistry, 32nd ed.

LONG ANSWER 5 — Definition and Types of Mutations

Definition

A mutation is a permanent, heritable change in the nucleotide sequence of DNA that may alter gene expression. Mutations may occur in:

Somatic cells → affect only that individual (e.g., cancer)
Germline cells → passed to offspring (e.g., genetic diseases)

Classification of Mutations

                    MUTATIONS
                       │
          ┌────────────┼────────────┐
     By size         By effect    By cause
          │                │            │
    Point mutations    Silent     Spontaneous
    Insertions         Missense   Induced
    Deletions          Nonsense   (radiation,
    Inversions         Frameshift  chemicals)
    Translocations

I. Point Mutations (Single Nucleotide Changes)

A single base is changed.

A. Substitution — Base Substitution

1. Transitions: Purine ↔ Purine or Pyrimidine ↔ Pyrimidine

A → G  (purine to purine)
C → T  (pyrimidine to pyrimidine)

2. Transversions: Purine ↔ Pyrimidine

A → C or T  (purine to pyrimidine)
G → A or T

B. Effect of Base Substitutions

Type	Effect	Example
Silent (Synonymous)	Codon changes but same amino acid (due to wobble in genetic code)	GGA→GGG both = Glycine
Missense	Codon changes → different amino acid	GAG→GTG: Glu→Val = Sickle Cell Anemia
Nonsense	Codon changes → stop codon (UAA/UAG/UGA) → premature termination	Thalassemia, Duchenne MD

II. Frameshift Mutations

Insertion or Deletion of nucleotides (not a multiple of 3) shifts the reading frame of all codons downstream.

Normal:  AUG-AAA-GGC-UCU-UAA
         Met-Lys-Gly-Ser-STOP

After 1 nucleotide insertion (insert 'C' after AUG):
         AUG-CAA-AGG-CUC-UUA-A...
         Met-Gln-Arg-Leu-Leu-... (COMPLETELY DIFFERENT!)

Insertions = add one or more bases → frameshift
Deletions = remove one or more bases → frameshift
Insertion/Deletion of multiples of 3 = in-frame mutation (adds/removes amino acids without frameshift)
Example: Cystic Fibrosis (ΔF508 — deletion of 3 bp → loss of Phe508 in CFTR)

III. Chromosomal Mutations (Large Scale)

Type	Description	Example
Inversion	Segment of chromosome reversed	Inv(9) — normal variant
Deletion	Segment lost	Cri-du-chat syndrome (5p deletion)
Duplication	Segment duplicated	Charcot-Marie-Tooth disease
Translocation	Segment moves to another chromosome	Philadelphia chromosome t(9;22) → CML

IV. Expansion Mutations (Trinucleotide Repeats)

Abnormal expansion of 3-nucleotide repeat sequences:

Disease	Repeat	Normal	Affected
Huntington's	CAG	<36	>40
Fragile X syndrome	CGG	<55	>200
Myotonic dystrophy	CTG	<37	>50

Anticipation = disease becomes worse in successive generations (repeats expand more).

V. Spontaneous vs Induced Mutations

┌─────────────────────┬────────────────────────────────────────┐
│ Spontaneous          │ Induced (Mutagenic Agents)            │
├─────────────────────┼────────────────────────────────────────┤
│ Replication errors   │ UV light → Thymine dimers             │
│ Depurination         │ X-rays, gamma rays → DSBs             │
│ Deamination of C→U   │ Alkylating agents (mustard gas)       │
│ Tautomeric shifts    │ Base analogs (5-bromouracil)           │
│                      │ Intercalating agents (acridine orange) │
│                      │ Nitrous acid (deaminates C→U)          │
└─────────────────────┴────────────────────────────────────────┘

VI. Beneficial vs Harmful Mutations

Harmful: Most mutations are harmful or neutral (e.g., sickle cell disease)
Beneficial: Rarely, a mutation improves fitness (basis of evolution)
Neutral/Silent: No change in phenotype
Sickle cell trait (heterozygous HbS) gives malaria resistance — a beneficial effect in endemic areas

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

📝 SHORT ANSWER QUESTIONS (5 Marks Each)

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

SHORT 1 — Different DNA Repair Mechanisms

DNA is constantly damaged by spontaneous errors, UV light, chemicals, and radiation. Multiple systems repair this damage:

1. Proofreading (3'→5' Exonuclease)

During replication, DNA Pol III checks each added nucleotide
Wrong nucleotide → removed immediately before continuing
Reduces error rate from 10⁻⁵ → 10⁻⁷

2. Mismatch Repair (MMR)

Fixes errors that escape proofreading
MutS detects mismatch → MutH cuts nearby → excision and resynthesis
Defect → Lynch syndrome (HNPCC)

3. Base Excision Repair (BER)

For small lesions (deamination, oxidation)
DNA glycosylase removes damaged base → AP endonuclease cuts backbone → Pol β fills → Ligase seals

4. Nucleotide Excision Repair (NER)

For bulky lesions (thymine dimers from UV)
~25 nt around the lesion is excised → gap filled → sealed
Defect → Xeroderma Pigmentosum (skin cancers, UV sensitivity)

5. Direct Repair / Photoreactivation

Photolyase uses visible light to directly reverse UV-induced thymine dimers

6. Double-Strand Break Repair

NHEJ (Non-Homologous End Joining): joins broken ends directly (error-prone)
HR (Homologous Recombination): uses sister chromatid as template (accurate)
BRCA1/BRCA2 → breast cancer when defective

SHORT 2 — Genetic Code and Its Characteristics

Definition

The genetic code is the set of rules by which the nucleotide sequence of mRNA is translated into an amino acid sequence of a protein. Three consecutive nucleotides form a codon, which specifies one amino acid.

There are 4³ = 64 possible codons for 20 amino acids + 3 stop codons.

Characteristics of the Genetic Code

┌─────────────────────────────────────────────────────────┐
│           PROPERTIES OF THE GENETIC CODE                │
├──────────────────────────────────┬──────────────────────┤
│ 1. Triplet code (codon = 3 bases)│ 3 bases per AA       │
│ 2. Non-overlapping               │ Each base read once  │
│ 3. Comma-free (no spacers)       │ Continuous reading   │
│ 4. Degenerate / Redundant        │ >1 codon per AA      │
│ 5. Universal (nearly)            │ Same in all organisms│
│ 6. Unambiguous (specific)        │ 1 codon = 1 AA only  │
│ 7. Start codon: AUG              │ = Methionine         │
│ 8. Stop codons: UAA, UAG, UGA    │ No AA assigned       │
│ 9. "Wobble" at 3rd position      │ 3rd base flexible    │
└──────────────────────────────────┴──────────────────────┘

Degeneracy (redundancy): Most amino acids have 2–6 codons (e.g., Leucine has 6 codons: UUA, UUG, CUU, CUC, CUA, CUG). This protects against silent mutations.

Wobble hypothesis (Crick): The 3rd base of the codon can pair with multiple bases in the anticodon → allows fewer tRNAs to serve all 64 codons.

Exceptions to universality:

Mitochondria use slightly different codes
Some ciliates use UAA/UAG for glutamine, not stop

SHORT 3 — Leading and Lagging Strands of DNA

During DNA replication, the replication fork moves in one direction. Both parental strands serve as templates, but since DNA polymerase can only synthesize in the 5'→3' direction, the two strands are replicated differently.

         ← Direction of fork movement

5'─────────────────────────────────────────── 3'   Parent strand 1
3'─────────────────────────────────────────── 5'   Parent strand 2
                        ↑
                  Replication fork

LEADING STRAND (continuous synthesis):
   3'──────────────────→ 5'  (template, read 3'→5')
   5'←────────────────── 3'  (new strand, synthesized 5'→3' toward fork)

LAGGING STRAND (discontinuous synthesis):
   5'──────────────────→ 3'  (template, read 5'→3', but polymerase goes other way)
   Synthesized as Okazaki fragments:
       [Fragment 3] ←── [Fragment 2] ←── [Fragment 1] ←──
         (joined by ligase after primer removal)

Feature	Leading Strand	Lagging Strand
Direction	Toward replication fork	Away from fork
Synthesis	Continuous	Discontinuous
Primers needed	One (at start)	One per Okazaki fragment
Okazaki fragments	No	Yes (1000–2000 nt in prokaryotes)
Final step	None extra	Primer removal + gap filling + ligation

SHORT 4 — Nucleotides + Names of 4 Nucleotides

What is a Nucleotide?

A nucleotide is the basic monomer (building block) of DNA and RNA. It has three components:

┌─────────────────────────────────────────────────┐
│              NUCLEOTIDE STRUCTURE               │
│                                                 │
│    ┌──────────────┐                             │
│    │  Nitrogenous │                             │
│    │     Base     │   (Purine or Pyrimidine)    │
│    └──────┬───────┘                             │
│           │  N-glycosidic bond                  │
│    ┌──────┴───────┐                             │
│    │  Pentose     │   Ribose (RNA) or            │
│    │  Sugar       │   Deoxyribose (DNA)          │
│    └──────┬───────┘                             │
│           │  Phosphoester bond                  │
│    ┌──────┴───────┐                             │
│    │  Phosphate   │   1, 2, or 3 phosphate       │
│    │  Group(s)    │   groups                     │
│    └──────────────┘                             │
└─────────────────────────────────────────────────┘

Nucleoside = Base + Sugar (no phosphate)
Nucleotide = Base + Sugar + Phosphate(s)
Nucleoside monophosphate (NMP): 1 phosphate → e.g., AMP
Nucleoside diphosphate (NDP): 2 phosphates → e.g., ADP
Nucleoside triphosphate (NTP): 3 phosphates → e.g., ATP (energy currency!)

Names of 4 Important Nucleotides (in DNA)

Nucleotide	Abbreviation	Base	Sugar
Deoxyadenosine monophosphate	dAMP	Adenine (purine)	Deoxyribose
Deoxyguanosine monophosphate	dGMP	Guanine (purine)	Deoxyribose
Deoxycytidine monophosphate	dCMP	Cytosine (pyrimidine)	Deoxyribose
Deoxythymidine monophosphate	dTMP	Thymine (pyrimidine)	Deoxyribose

In RNA, thymine (T) is replaced by Uracil (U) → UMP

SHORT 5 — Onion Peel Model of DNA Replication

What is it?

The onion peel (or unfolding) model describes how DNA replication proceeds in eukaryotes where chromosomal DNA is tightly packed into chromatin (DNA + histones). The name comes from the idea that the chromatin opens up layer by layer like peeling an onion, to allow replication machinery access to the DNA.

Key Points

CHROMATIN STRUCTURE:
DNA wraps around histone octamers → Nucleosome → "Beads on a string"
Nucleosomes fold → 30 nm fiber → loops → higher order structure

BEFORE REPLICATION:
 ┌──────────────────────────────────────────────┐
 │  Compact chromatin: DNA inaccessible         │
 └──────────────────────────────────────────────┘

DURING REPLICATION (Onion Peel Model):
 ┌──────────────────────────────────────────────┐
 │  1. Histones acetylated → chromatin opens    │
 │  2. Nucleosomes dissemble ahead of fork      │
 │  3. DNA is unwound and replicated            │
 │  4. Nucleosomes reassemble behind fork       │
 │     (new histones added — half old, half new)│
 │  5. Chromatin re-condenses                   │
 └──────────────────────────────────────────────┘

Significance

Explains how tightly packed eukaryotic DNA (2 meters packed into 6 µm nucleus) can be replicated
Histone chaperones (like CAF-1) help reassemble nucleosomes post-replication
Epigenetic marks (methylation patterns) must also be reproduced — epigenetic inheritance

SHORT 6 — Okazaki Fragments + What is Gout?

Okazaki Fragments

Definition: Short, discontinuously synthesized fragments of DNA formed on the lagging strand during DNA replication.

Why are they formed? Because DNA Pol III can only synthesize DNA in the 5'→3' direction, but the lagging strand template runs in the 3'→5' direction opposite to fork movement. So instead of one continuous strand, DNA is made in short backward pieces.

Fork moves this way: ──────────────→

Lagging strand template:
5'───────────────────────────────────────3'
←Fragment 3  ←Fragment 2  ←Fragment 1
[RNA primer][DNA]  [RNA primer][DNA]  [RNA primer][DNA]
                                        ↑ Made first

Feature	Details
Size in prokaryotes	1,000 – 2,000 nucleotides
Size in eukaryotes	100 – 200 nucleotides
Discovered by	Reiji & Tuneko Okazaki (1968)
Starts with	RNA primer (made by Primase)
Final step	Primers removed by DNA Pol I → gaps filled → DNA Ligase joins them

Important: Failure to join Okazaki fragments → strand breaks → genome instability.

Gout — Definition and Biochemistry

Definition: Gout is a metabolic disorder characterized by hyperuricemia (high uric acid in blood) and deposition of monosodium urate crystals in joints, soft tissues, and kidneys, causing painful arthritis.

Pathophysiology

Purine metabolism pathway:
AMP / GMP / IMP
       ↓
   Xanthine
       ↓  [Xanthine Oxidase]
   URIC ACID
       ↓
Normal: Excreted in urine (soluble)
In Gout: Overproduced OR underexcreted → HYPERURICEMIA
             ↓
   Urate crystals form in joints (especially big toe = podagra)
             ↓
   Neutrophils engulf crystals → Inflammation → PAINFUL ATTACK

Types of Gout

Type	Cause
Primary gout	Inherited HGPRT deficiency (Lesch-Nyhan), PRPP synthetase overactivity
Secondary gout	High cell turnover (leukemia, psoriasis), renal failure, diuretics

Clinical Features

Podagra = acute gout in the big toe (most common)
Tophi = chalky urate deposits in earlobes, joints
Nephrolithiasis (kidney stones) — uric acid stones
Acute arthritis — sudden, severe joint pain, redness, swelling

Treatment

Drug	Mechanism	Phase
Colchicine	Inhibits neutrophil migration (anti-inflammatory)	Acute attack
NSAIDs (indomethacin)	Anti-inflammatory	Acute attack
Allopurinol	Inhibits xanthine oxidase → ↓ uric acid production	Chronic/prophylaxis
Febuxostat	Inhibits xanthine oxidase (non-purine analog)	Chronic
Probenecid	Increases renal uric acid excretion (uricosuric)	Chronic

Allopurinol is the most commonly tested treatment in exams — it is a structural analog of hypoxanthine and acts as a competitive suicide inhibitor of xanthine oxidase.

📌 QUICK REVISION SUMMARY CARD

┌─────────────────────────────────────────────────────────────────────┐
│                    BIOCHEMISTRY EXAM CHEAT SHEET                   │
├───────────────────┬─────────────────────────────────────────────────┤
│ Purine de novo    │ PRPP→PRA(committed)→IMP→AMP/GMP                │
│ Pyrimidine de novo│ Carbamoyl-P→OMP→UMP→CTP/TMP                    │
│ DNA Replication   │ Initiation→Priming→Elongation→Ligation          │
│ Leading strand    │ Continuous, toward fork                         │
│ Lagging strand    │ Discontinuous, Okazaki fragments                │
│ DNA Repair        │ Proofreading, MMR, BER, NER, NHEJ, HR           │
│ Translation steps │ Charging→Initiation→Elongation→Termination      │
│ Genetic code      │ Triplet, degenerate, universal, non-overlapping │
│ Mutation types    │ Silent, missense, nonsense, frameshift          │
│ Gout              │ ↑Uric acid → urate crystals → treat:Allopurinol│
└───────────────────┴─────────────────────────────────────────────────┘

Sources: Lippincott's Illustrated Reviews: Biochemistry 8th ed.; Harper's Illustrated Biochemistry 32nd ed.; Emery's Elements of Medical Genetics; Thompson & Thompson Genetics in Medicine 9th ed.

This is a shared conversation. Sign in to Orris to start your own chat.